Objective: Intradialysis hypertension (IDH) is a frustrating complication among hemodialysis (HD) patients, and the causes are complex. Volume excess is thought to be important in the pathogenesis of hypertension among HD patients. The purpose of this study was to investigate whether additional volume reduction will result in improvement in IDH, and to evaluate the hemodynamic tolerance of the IDH patients. Methods: A prospective, open-label, single center study of 22 patients with IDH, undergoing chronic intermittent hemodialysis at the Tongji Hospital of Shanghai. Eleven patients with pre-dialytic hypertension entered in Group A, and other 11 patients with normal pre-dialytic blood pressure were in Group B. In both groups we give the patients dry-weight reduction. Blood pressure was monitored per dialysis session. The mean weights of the first treatment in the baseline period, and the third treatment at week 4 were taken. As to the assessment of subjective tolerance, we decided to administer the questionnaire designed by Cruz et al. The questionnaire was administered to patients at the end of each dialysis run. Results: The primary outcome was change in systolic interdialytic ambulatory BP. In Group A, the postdialysis weight was reduced by 0.67 kg at 4 weeks and resulted in À12.55 mmHg (95% CI: À22.39 to À2.69 mmHg; p Z 0.022) change in pro-systolic BP and À6.73 mmHg (95% CI: À10.75 to À2.7 mmHg; p Z 0.078) change in pro-diastolic BP. In Group B, the postdialysis weight was reduced by 0.18 kg at 4 weeks and resulted in 3.72 mmHg (95% CI: À10.12 to 17.57 mmHg; p Z 0.524) change in pro-systolic BP and À0.81 mmHg (95% CI: À10.96 to 9.33 mmHg; p Z 0.519) change in pro-diastolic BP. The mean score subjectively assigned by patients to dialysis quality on a 1e10 analog scale during each dialysis run was as follow: Group A: 9.3 AE 0.76 vs. Group B: 8.8 AE 1.32 (p Z 0.13). Conclusion: This study suggests that the further reduction of dry weight is an efficacious and well-tolerated maneuver to improve BP control in IDH patients with pre-dialytic hypertension. However, for those patients who have normal pre-dialytic hypertension, the volume excess might not be the main cause for IDH. Other causes involved have to be further researched. Objective: To analyze the risk of factor for catheter-releted infection in the patients with tunneled hemodialysis catheters and the treatment of pathogens. Provide a reference for further prevention and treatment of catheter infections. Methods: A total of 155 patients carried the tunneled hemodialysis catheters, male 89 cases, female 66 cases. And 22 patients in our hospital diagnosed catheter infection which occurs. Long-term indwelling catheters for use in patients with general information (gender, age, BMI, smoking history), primary disease, albumin levels, anemia, indwelling catheter time and other factors compared to patients infected with the catheter and catheter infection pathogens statistics types, sensitivity analysis and treatment factors were analyzed. Using SPSS 17.0 statistical software for analysis. Results: Multiple logistic regression analysis showed that diabetes mellitus, blood sugar level, hemoglobin, hypoproteinemia, deep vein indwelling catheter time were the risk factors for catheter-related infection. Catheter main pathogens of Gram-positive bacteria accounted for 60.5%, Gram-negative bacteria accounted for 39.5%. Objective: To investigate the clinical effect of atorvastatin combined with far-infrared radiation on autogenous arteriovenous fistula in patients with chronic kidney disease undergoing maintenance hemodialysis. Methods: Patients used autogenous arteriovenous fistula more than one year in Guizhou Provincial People's Hospital hemodialysis centers were randomly divided into combination therapy group and control group. Patients in combination therapy group treatment with atorvastatin combined with far-infrared radiation, control group, matched with age and sex, were not treated with atorvastatin. Blood flow changes and the incidence of fistula dysfunction were detected by Doppler ultrasound. Demographic characteristics, high-sensitivity C-reactive protein (hs-CRP) fibrinogen, D-dimer, hemoglobin, lipids, and hemodialysis adequacy (Kt/v) were collected. After 1-year follow-up, the incidence of fistula thrombosis and blood flow changes were compared in two groups. Results: Compared with the control group, after combination therapy for 1 year hemodialysis adequacy were significantly higher (P < 0.05) and hs-CRP, total cholesterol, LDL-C, D-dimer were decreased. Blood flow value in combination therapy group was higher than control group (P < 0.05). At the end of follow-up, one case in combination therapy group and 3 cases in control group experienced AVF dysfunction (97.36% vs. 93.02%). Dialysis S133
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